Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of OraVescent fentanyl
when used long-term to relieve breakthrough pain in opioid tolerant cancer patients.